Trials / Recruiting
RecruitingNCT05997030
Low-Intensity Focused Ultrasound (LIFU) Neuromodulation
Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Ali Rezai · Academic / Other
- Sex
- All
- Age
- 45 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with mild cognitive impairment ( MCI) due to Alzheimer's disease.
Detailed description
The primary objective is to evaluate the safety, feasibility and tolerability of LIFU as an adjunct neuromodulatory treatment for MCI due to AD
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | low intensity focused ultrasound (LIFU) | Subjects will undergo undergo a single LIFU of the target brain region |
Timeline
- Start date
- 2023-10-12
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
- First posted
- 2023-08-18
- Last updated
- 2025-11-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05997030. Inclusion in this directory is not an endorsement.